According to NanoViricides's latest financial reports and stock price the company's current number of shares outstanding is 11,745,906. At the end of 2023 the company had 11,745,906 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 11.74 M | 1.17% |
2022 | 11.61 M | 0.74% |
2021 | 11.52 M | 8.06% |
2020 | 10.66 M | 176.76% |
2019 | 3.85 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Gilead Sciences GILD | 1,248,000,000 | 10,524.98% | ๐บ๐ธ USA |
Merck MRK | 2,554,166,667 | 21,645.17% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | 2,023,000,000 | 17,123.02% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | 2,028,000,000 | 17,165.59% | ๐ฌ๐ง UK |
Novavax NVAX | 103,429,000 | 780.55% | ๐บ๐ธ USA |
BioCryst Pharmaceuticals
BCRX | 189,644,000 | 1,514.55% | ๐บ๐ธ USA |